Table 1.
Clinical characteristics of the PH patients.
| Parameter | Non-Survival Group (n = 12) | Survival Group (n = 31) | p Value |
|---|---|---|---|
| Age (years) | 56.0 [43.8–70.8] | 55.0 [44.0–70.0] | 0.840 |
| Women/men (n (%)) | 7 (25)/5 (33.3) | 21 (75)/10 (66.7) | 0.561 * |
| IPAH (n (%)) | 3 (25) | 10 (32.3) | 0.643 * |
| PHSsc (n (%)) | 3 (25) | 5 (16.1) | 0.505 * |
| Eisenmenger syndrome (n (%)) | 4 (33.3) | 9 (29.0) | 0.784 * |
| CTEPH (n (%)) | 2 (16.7) | 7 (22.6) | 0.672 * |
| NYHA class 2/3/4 (n (%)) | 3 (25)/6 (50)/3 (25) | 6 (19.4)/20 (64.5)/5 (16.1) | 0.708 ** |
| mPAP (mmHg) | 56.5 [41.75–64.75] | 54.0 [44.0–72.0] | 0.753 |
| 6MWT (m) | 270 [160.0–406.0] | 313.5 [250.0–380.75] | 0.488 |
| NT-pro BNP (ng/mL) | 2588.0 [1215.5–5521.0] | 763.0 [238.0–2156.0] | 0.022 |
Values are median [interquartile range] or n (%). NYHA—New York Heart Association functional class; 6MWT—six minutes walking test; NT pro BNP—brain natriuretic peptide; mPAP—mean pulmonary artery pressure. p value by Mann-Whitney U test * or Chi-square test **. NYHA p = 0.708, χ2 = 0.799, df = 2.